Maternal Brain-Derived Neurotrophic Factor Associations with Hyperemesis Gravidarum Severity, Postpartum Depressive Symptoms, and Neonatal Outcomes: A Prospective Indonesian Cohort Study
This prospective Indonesian cohort study of 88 pregnant women reveals that lower maternal Brain-Derived Neurotrophic Factor (BDNF) levels are significantly associated with increased Hyperemesis Gravidarum severity, higher early postpartum depressive symptoms, and poorer neonatal outcomes, suggesting BDNF reflects a shared neurotrophic response to the physiological and psychological burdens of severe pregnancy complications.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Pregnancy is a time of profound transformation, where a woman's body and mind navigate a complex landscape of physiological shifts. Among the most challenging of these changes is hyperemesis gravidarum, a severe form of morning sickness that goes far beyond typical nausea. Unlike the occasional queasiness many expect, this condition involves relentless vomiting, significant weight loss, and a dangerous imbalance of fluids and nutrients that often requires hospital care. Alongside this physical toll, the postpartum period brings its own psychological hurdles, with many new mothers facing the shadow of depression. For decades, scientists have searched for the biological threads that might tie these experiences together. One such thread is brain-derived neurotrophic factor, or BDNF. Think of BDNF as a vital nutrient for the brain's nerve cells, helping them survive, grow, and adapt to stress. While it is well known in the brain, this protein is also found in the blood and even in reproductive tissues, leading researchers to wonder if its levels could serve as a biological signal linking the severity of morning sickness, the risk of postpartum depression, and the health of the newborn.
In a prospective study conducted in Makassar, Indonesia, a team of researchers set out to trace these connections within a single group of women. They followed 88 pregnant women from their first trimester through to the birth of their babies and the early weeks of motherhood. The goal was not just to look at these conditions in isolation, but to see if a single biological marker could reflect the burden of severe vomiting, the emergence of depressive symptoms, and the physical growth of the infant. The researchers recruited women who were already experiencing symptoms of hyperemesis gravidarum during the first trimester and carefully measured their blood levels of BDNF during the third trimester. They then tracked the severity of their vomiting using a standard questionnaire, assessed their mental health four weeks after delivery using two widely recognized screening tools, and recorded the birth weight and length of their babies.
The results revealed a clear and consistent pattern. The study found that women with lower levels of BDNF in their blood were the same women who suffered from the most severe vomiting, reported the highest levels of depressive symptoms after giving birth, and had babies with smaller birth weights and lengths. Specifically, the women whose vomiting was classified as severe had significantly lower BDNF levels, averaging 16.41 nanograms per milliliter, compared to those with moderate symptoms, who averaged 26.03 nanograms per milliliter. This difference was substantial, suggesting that as the physical burden of the illness increased, the protective neurotrophic factor in the blood decreased. The link to mental health was equally striking. Women who screened positive for postpartum depression had BDNF levels that were nearly 10 nanograms per milliliter lower than those who did not. In fact, every woman in the study who had severe vomiting also screened positive for probable depression, and all of them exhibited moderate levels of depressive symptoms.
When the researchers looked at the babies, the story continued. Higher levels of maternal BDNF were associated with larger babies, both in terms of weight and length. While the connection was strongest with birth weight, the data showed that mothers with higher BDNF levels tended to give birth to infants who were heavier and longer than those born to mothers with lower levels. The study suggests that BDNF may not be a direct cause of these outcomes, but rather a shared biological response to the immense nutritional, metabolic, and psychological stress that severe hyperemesis gravidarum places on a woman's body. The persistent vomiting likely depletes essential nutrients and creates a state of oxidative stress, which in turn may lower the production of this critical brain nutrient. This depletion appears to leave the mother more vulnerable to depression and may signal a less optimal environment for fetal growth.
It is important to note that while these associations are strong, the study does not prove that low BDNF causes depression or that it directly determines a baby's size. The researchers emphasize that their findings show a link, not a chain of command. The study also highlights that BDNF levels can vary depending on the timing of the test and the specific methods used to measure them, meaning it cannot yet be used as a standalone diagnostic tool in a clinic. However, the work provides a crucial piece of the puzzle, bringing together the physical trauma of severe morning sickness, the emotional weight of postpartum depression, and the physical reality of newborn size into one coherent picture. By identifying that these three distinct challenges often travel together and are reflected in the same biological marker, the study points toward a future where care for pregnant women might address these issues as an interconnected whole, rather than as separate problems. The findings suggest that the body's response to the extreme stress of hyperemesis gravidarum may ripple outward, affecting the mother's mind and the baby's growth in ways that are now beginning to be understood.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.